UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of
February 2025 (Report No. 1)
Commission file number: 001-41387
SaverOne 2014 Ltd.
(Translation of registrant’s name into English)
Em Hamoshavot Rd. 94
Petah Tikvah, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
The press release attached to this Form 6-K is
hereby incorporated by reference into the registrant’s Registration Statements on Form
S-8 (File No. 333-274455) and Form F-3 (File No. 333-274458, 333-263338 and 333-269260),
to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently
filed or furnished.
CONTENTS
Attached hereto and incorporated herein is the Registrant’s press
release issued on February 4, 2025, titled “SaverOne Announces New Deployment of Its Driver
Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet.”
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Date: February 4, 2025 |
SAVERONE 2014 LTD. |
|
|
|
|
By: |
/s/ Ori Gilboa |
|
Name: |
Ori Gilboa |
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1

SaverOne
Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet
Teva,
a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel
Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE
NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in transportation safety technology, today
announced the award of a new contract with Teva Pharmaceutical Industries Ltd. (Teva), to install the SaverOne System across its entire
fleet of 50 pharmaceutical delivery trucks. This follows the successful initial deployment in 14 trucks.
Headquartered in Israel, Teva is a multinational
pharmaceutical company and one of the world’s largest generic drug manufacturers. Teva operates a global fleet supporting its supply
chain across more than 60 countries.
Mr. Ori Gilboa, CEO of SaverOne commented,
“We are proud of this new collabortion with Teva, a global pharmaceutical leader, in supporting the safety of their drivers and
deliveries. While we look forward to successfully completing the installation in Israel across all 50 of their trucks, we believe there
is strong future potential for further deployments in other countries within Teva’s global fleets and operations. This win underscores
continued growing demand for our technology and highlights our ability to deliver effective solutions that help prevent driver distractions
in commercial fleets.”
Mr. Ronen Talmor, Traffic Safety Officer at
Teva, commented, “As a company that places safety as a top priority, whether workplace safety or road safety, we invest significant
time and money in technological solutions and training to prevent accidents. When we discovered SaverOne’s system, which essentially
complements our efforts as a company to prevent road accidents and eliminate the number one cause of such accidents - driver distraction,
we immediately recognized its value. I believe that any company that, like us, prioritizes safety will not overlook this highly significant
system.”
About the SaverOne System
SaverOne's system is installed in vehicles to
solve the problem of driver distraction, as a result of drivers using distracting applications on their mobile phones while driving in
a way that endangers their safety and the safety of their passengers. This phenomenon is considered one of the leading causes of global
road accidents. According to the US National Highway Traffic Safety Administration, the annual cost of road accidents just in the United
States stands at about $870 billion each year, excluding the costs of serious injury or death, with a quarter of those accidents estimated
to be related to the use of the mobile phones while driving. SaverOne's technology specifically recognizes the driver area in the vehicle.
It prevents the driver from accessing distracting applications such as messaging while allowing others (navigation as an example) without
user intervention or consent, creating a safer driving environment.
SaverOne's primary target markets include commercial
and private vehicle fleets interested in reducing potential damages and significant costs, vehicle manufacturers interested in integrating
safety solutions into their vehicles, and insurance and leasing companies. SaverOne initially addresses car fleets with a focus on the
Israeli, European, and US markets and other markets worldwide. SaverOne believes that an increased focus on monitoring and prevention
of cellular distraction systems in vehicles, driven by upcoming expected EU regulation, will likely have a dramatic positive impact on
the demand for its systems in the future.
The Company's strategy is to provide its technology
to customers in the aftermarket and address OEM vehicle manufacturers to integrate the Company's protection technologies during the vehicle
manufacturing process.
About SaverOne
SaverOne is a technology company that designs,
develops, and commercializes OEM and aftermarket solutions and technologies to lower the risk of and prevent vehicle accidents.
SaverOne's initial product line is a suite of
solutions that saves lives by preventing car accidents resulting from distraction from using mobile phones while driving. SaverOne is
also developing a sensor system for early location and direction detection under all visibility conditions of vulnerable road users (VRU)
through their cellphone footprint.
Learn more at https://saver.one/

Forward Looking Statements
This press release contains "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws that are subject to substantial
risks and uncertainties. All statements, besides those of historical fact, contained in this press release are forward-looking. Forward-looking
statements contained in this press release include but are not limited to, statements regarding SaverOne's strategic and business plans,
technology, relationships, objectives, and expectations for its business, the impact of trends on and interest in its business, intellectual
property or product and its future results, operations, and financial performance and condition and may be identified by the use of words
such as "anticipate," "believe," "contemplate," "could," "estimate," "expect,"
"intend," "seek," "may," "might," "plan," "potential," "predict,"
"project," "target," "aim," "should," "will" "would," or the negative of these
words or other similar expressions. However, not all forward-looking statements contain these words. Forward-looking statements are based
on SaverOne's current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further,
certain forward-looking statements are based on assumptions about future events that may not prove accurate. Many factors could cause
SaverOne's actual activities or results to differ materially from those anticipated in such forward-looking statements. Factors that could
cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited
to: the ability of our technology to substantially improve the safety of drivers; SaverOne’s planned level of revenues and capital
expenditures and its ability to continue as a going concern; SaverOne’s ability to maintain its listing on the Nasdaq Capital Market; the
ability of SaverOne’s technology to substantially improve the safety of drivers; SaverOne’s ability to broaden the footprint
of its product and services within Teva globally and to market and sell its products generally; SaverOne’s plans to continue to
invest in research and development to develop technology for both existing and new products; SaverOne’s intention to advance its
technologies and commercialization efforts; SaverOne’s plan to seek patent, trademark and other intellectual property rights for
products and technologies in the United States and internationally, as well as its ability to maintain and protect the validity of currently
held intellectual property rights; SaverOne’s expectations regarding future changes in its cost of revenues and operating expenses;
interpretations of current laws and the passage of future laws; acceptance of its business model by investors; the ability to correctly
identify and enter new markets; the impact of competition and new technologies; general market, political and economic conditions in the
countries in which SaverOne operates; projected capital expenditures and liquidity; SaverOne’s intention to retain key employees,
and its belief that it will maintain good relations with all employees; a resurgence of the COVID-19 pandemic and its impact on business
and industry; as well as other risks and uncertainties, including, but not limited to, the risks detailed in the Company's Annual Report
on Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC") on March 25, 2024 and in subsequent filings
with the SEC. Forward-looking statements in this announcement are made as of this date, and SaverOne undertakes no duty to update such
information except as required under applicable law.
International Investor Relations Contact:
Ehud Helft
+1 212 378 8040
saverone@ekgir.com
|
|
SaverOne 2014 (NASDAQ:SVREW)
Historical Stock Chart
From Feb 2025 to Mar 2025
SaverOne 2014 (NASDAQ:SVREW)
Historical Stock Chart
From Mar 2024 to Mar 2025